Development of Drug Release Model for Suspensions in ESCAR (Emulator of SubCutaneous Absorption and Release).

Autor: Lou H; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, 66047, USA. lou0@ku.edu.; Biopharmaceutical Innovation and Optimization Center, University of Kansas, Lawrence, KS, 66047, USA. lou0@ku.edu., Hageman MJ; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, 66047, USA. mhageman@ku.edu.; Biopharmaceutical Innovation and Optimization Center, University of Kansas, Lawrence, KS, 66047, USA. mhageman@ku.edu.
Jazyk: angličtina
Zdroj: The AAPS journal [AAPS J] 2023 Mar 22; Vol. 25 (3), pp. 29. Date of Electronic Publication: 2023 Mar 22.
DOI: 10.1208/s12248-023-00799-1
Abstrakt: We recently developed an in vitro testing system, namely, ESCAR (Emulator of SubCutaneous Absorption and Release). The objective of this work was to investigate drug release behaviors of unmilled and milled suspensions in ESCAR. A mass transport-based model was developed to describe the multi-step drug release process, including drug dissolution, particle settling, drug distribution/partition, and drug permeation through the membrane(s). To address the particle settling effect, a correction factor was included in the model and its value was obtained by data fitting. It was found that, for both suspensions, (i) the experimental data of various dose/formulation combinations could be fit by the developed model; (ii) the dose effect on drug release was offset by the particle settling effect. This model may help to reduce experimental efforts and facilitate subcutaneous suspension formulation development using ESCAR.
(© 2023. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists.)
Databáze: MEDLINE
Externí odkaz: